Nanobody Engineering: Toward Next Generation Immunotherapies and Immunoimaging of Cancer

Timothée Chanier, Patrick Chames
Journal
ISSN / E-ISSN
— / —
DOI
10.3390/antib8010013 ↗
Volume · Issue · Pages
8 · 1 · 13-13
Publisher
MDPI AG
Article URL
http://dx.doi.org/10.3390/antib8010013 ↗
Article details
Unverified
Publication date (each date has its type and source)
21 Jan 2019
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date21 Jan 2019 OpenAlex

Keywords (as given): nanobodies; VHH single-domain antibodies; cancer immunotherapy; tumor immune infiltrate; bispecific antibodies; multispecific antibodies; multivalent antibodies; camelid antibodies; von Willebrand factor; caplacizumab; acquired thrombotic thrombocytopenic purpura; tumor targeting

HEC Status at Publication Not the journal's current status

HEC Status at PublicationNot conclusive
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Journal
Antibodies
Publication date used
21 Jan 2019 (OpenAlex publication date)
Applicable HEC period
None recorded for this date
Category
—
Recognition status
Unknown (NO_PERIOD_FOR_DATE)
Source
—
Verification status
Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.